TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Randomised Controlled Trial of the Clinical and Cost Effectiveness of NICE Recommended Problem Solving Cognitive Behaviour Therapy (PS CBT) Delivered Remotely Versus Treatment as Usual in Adolescents and Young Adults With Depression Who Repeatedly Self-harm
Brief Summary: A randomized controlled trial to test the whether remote delivery of cognitive based therapy (CBT) is clinically and cost effective when compared to treatment as usual in adolescents and young adults with depression who self-harm.


Options:
A: Arm Label: Zolpidem-CR; Type: ACTIVE_COMPARATOR; Interventions: Drug: Zolpidem-CR | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Zolpidem-CR; Assigned to Arm(s): Zolpidem-CR | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
B: Arm Label: Relaxation group; Type: ACTIVE_COMPARATOR; Interventions: Other: Relaxation group | Arm Label: Psychoeducational group; Type: EXPERIMENTAL; Interventions: Behavioral: Interventional group : PEPSUI psychoeducational program | Intervention Type: BEHAVIORAL; Name: Interventional group : PEPSUI psychoeducational program; Assigned to Arm(s): Psychoeducational group | Intervention Type: OTHER; Name: Relaxation group; Assigned to Arm(s): Relaxation group
C: Arm Label: PS CBT; Type: EXPERIMENTAL; Interventions: Behavioral: Problem solving cognitive behaviour therapy (PS CBT) | Arm Label: Treatment as Usual; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Problem solving cognitive behaviour therapy (PS CBT); Assigned to Arm(s): PS CBT
D: Arm Label: Post Admission Cognitive Therapy (PACT); Type: EXPERIMENTAL; Interventions: Behavioral: Post Admission Cognitive Therapy (PACT) | Arm Label: Enhanced Usual Care (EUC); Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Post Admission Cognitive Therapy (PACT); Assigned to Arm(s): Post Admission Cognitive Therapy (PACT)

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Randomised Controlled Trial of the Clinical and Cost Effectiveness of NICE Recommended Problem Solving Cognitive Behaviour Therapy (PS CBT) Delivered Remotely Versus Treatment as Usual in Adolescents and Young Adults With Depression Who Repeatedly Self-harm
Brief Summary: A randomized controlled trial to test the whether remote delivery of cognitive based therapy (CBT) is clinically and cost effective when compared to treatment as usual in adolescents and young adults with depression who self-harm.


Options:
A: Arm Label: PS CBT; Type: EXPERIMENTAL; Interventions: Behavioral: Problem solving cognitive behaviour therapy (PS CBT) | Arm Label: Treatment as Usual; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Problem solving cognitive behaviour therapy (PS CBT); Assigned to Arm(s): PS CBT
B: Arm Label: F-SPS Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: F-SPS+UC | Arm Label: Enhanced Usual Care (EUC); Type: ACTIVE_COMPARATOR; Interventions: Behavioral: EUC | Intervention Type: BEHAVIORAL; Name: F-SPS+UC; Assigned to Arm(s): F-SPS Intervention | Intervention Type: BEHAVIORAL; Name: EUC; Assigned to Arm(s): Enhanced Usual Care (EUC)
C: Arm Label: Informational Sessions; Type: SHAM_COMPARATOR; Interventions: Behavioral: Informational sessions describing BPD characteristics | Arm Label: Condensed-DBT treatment intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Condensed-DBT treatment intervention | Intervention Type: BEHAVIORAL; Name: Informational sessions describing BPD characteristics; Assigned to Arm(s): Informational Sessions | Intervention Type: BEHAVIORAL; Name: Condensed-DBT treatment intervention; Assigned to Arm(s): Condensed-DBT treatment intervention
D: Arm Label: therapy; Type: EXPERIMENTAL; Interventions: Behavioral: Cognitive behavioural therapy | Arm Label: Standard treatment; Type: ACTIVE_COMPARATOR; Interventions: Other: Standard treatment | Intervention Type: BEHAVIORAL; Name: Cognitive behavioural therapy; Assigned to Arm(s): therapy | Intervention Type: OTHER; Name: Standard treatment; Assigned to Arm(s): Standard treatment

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Lowering Blood Pressure in Primary Care in Vienna
Brief Summary: The aim of this prospective, randomised, open-label, multicentre clinical trial is to enhance blood pressure control in primary care by introducing a standardised and simplified titration regime with single pill combinations (SPC), comprising an angiotensin receptor blocker, calcium channel blocker and hydrochlorothiazide.


Options:
A: Arm Label: Candesartan; Type: EXPERIMENTAL; Interventions: Drug: candesartan, Drug: nifedipine, long acting, Drug: metoprolol, long-acting | Arm Label: Lisinopril; Type: EXPERIMENTAL; Interventions: Drug: lisinopril, Drug: nifedipine, long acting, Drug: metoprolol, long-acting | Arm Label: HCTZ; Type: ACTIVE_COMPARATOR; Interventions: Drug: hydrochlorothiazide | Intervention Type: DRUG; Name: candesartan; Assigned to Arm(s): Candesartan | Intervention Type: DRUG; Name: lisinopril; Assigned to Arm(s): Lisinopril | Intervention Type: DRUG; Name: hydrochlorothiazide; Assigned to Arm(s): HCTZ | Intervention Type: DRUG; Name: nifedipine, long acting; Assigned to Arm(s): Candesartan, Lisinopril | Intervention Type: DRUG; Name: metoprolol, long-acting; Assigned to Arm(s): Candesartan, Lisinopril
B: Arm Label: Intensive Control of SBP; Type: EXPERIMENTAL; Interventions: Drug: Intensive control of SBP | Arm Label: Standard Control of SBP; Type: ACTIVE_COMPARATOR; Interventions: Drug: Standard control of SBP | Intervention Type: DRUG; Name: Intensive control of SBP; Assigned to Arm(s): Intensive Control of SBP | Intervention Type: DRUG; Name: Standard control of SBP; Assigned to Arm(s): Standard Control of SBP
C: Arm Label: Standard Care; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Experimental Care; Type: EXPERIMENTAL; Interventions: Drug: Olmesartan medoxomil, amlodipine, hydrochlorothiazide | Intervention Type: DRUG; Name: Olmesartan medoxomil, amlodipine, hydrochlorothiazide; Assigned to Arm(s): Experimental Care
D: Arm Label: A,1,IV; Type: ACTIVE_COMPARATOR; Interventions: Drug: Amlodipine, Telmisartan, Amiloride Compound , Simvastatin | Arm Label: A,2,IV; Type: ACTIVE_COMPARATOR; Interventions: Drug: Amlodipine, Telmisartan, Amiloride Compound , Simvastatin | Arm Label: A,3,IV; Type: ACTIVE_COMPARATOR; Interventions: Drug: Amlodipine, Telmisartan, Amiloride Compound , Simvastatin | Arm Label: A,4,IV; Type: ACTIVE_COMPARATOR; Interventions: Drug: Amlodipine, Telmisartan, Amiloride Compound , Simvastatin | Intervention Type: DRUG; Name: Amlodipine, Telmisartan, Amiloride Compound , Simvastatin; Assigned to Arm(s): A,1,IV, A,2,IV, A,3,IV, A,4,IV

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Single Blind, Randomised, Controlled Trial to Evaluate the Effectiveness of Transcutaneous Posterior Tibial Nerve Stimulation (TPTNS) in Overactive Bladder (OAB) Symptoms in Women Responders to Posterior Tibial Nerve Stimulation (PTNS)
Brief Summary: This study will help to determine the effectiveness of a self-supervised, home-based Transcutaneous Posterior Tibial Nerve Stimulation treatment protocol in maintaining Overactive Bladder (OAB) symptoms improvement in women responders to Posterior Tibial Nerve Stimulation (PTNS)


Options:
A: Arm Label: Urgent PC; Type: ACTIVE_COMPARATOR; Interventions: Device: Urgent PC | Intervention Type: DEVICE; Name: Urgent PC; Assigned to Arm(s): Urgent PC
B: Arm Label: Urgent PC; Type: ACTIVE_COMPARATOR; Interventions: Device: Urgent PC Neuromodulation System | Arm Label: Sham / Placebo; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: Urgent PC Neuromodulation System; Assigned to Arm(s): Urgent PC
C: Arm Label: Urgent PC treatment arm; Type: EXPERIMENTAL; Interventions: Device: Urgent PC Neuromodulation System, Drug: Tolterodine | Intervention Type: DEVICE; Name: Urgent PC Neuromodulation System; Assigned to Arm(s): Urgent PC treatment arm | Intervention Type: DRUG; Name: Tolterodine; Assigned to Arm(s): Urgent PC treatment arm
D: Arm Label: Percutaneus Stimulation; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Percutaneus Stimulation | Arm Label: Transcutaneous Stimulation; Type: EXPERIMENTAL; Interventions: Device: Transcutaneous Stimulation | Intervention Type: DEVICE; Name: Transcutaneous Stimulation; Assigned to Arm(s): Transcutaneous Stimulation | Intervention Type: PROCEDURE; Name: Percutaneus Stimulation; Assigned to Arm(s): Percutaneus Stimulation

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Making Effective HPV Vaccine Recommendations
Brief Summary: Coverage of HPV vaccination among US teens is low, far below Healthy People 2020 goals. A central reason for low coverage is infrequent and inadequate healthcare provider recommendation of HPV vaccine. The proposed intervention aims to train clinicians to provide effective recommendations for the vaccine using participatory or efficient communication strategies.

This study will evaluate the effectiveness of two communication trainings to increase HPV vaccination coverage among adolescent patients. We will compare HPV vaccination for pediatric and family medicine clinics receiving a participatory communication training, efficient communication training, or no training. Ten clinics will be randomly assigned to each study arm for a total of 30 clinics. The primary outcome of this study is to compare the change in clinics' levels of HPV vaccination initiation coverage among 11-12 year old adolescent patients from baseline to 6 month follow-up. Secondarily, we will compare the change in HPV vaccination initiation coverage in 13-17 year old adolescents.


Options:
A: Arm Label: Intervention Clinics; Type: EXPERIMENTAL; Interventions: Behavioral: Academic Detailing | Arm Label: Control Clinics; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Academic Detailing; Assigned to Arm(s): Intervention Clinics
B: Arm Label: Intervention Group Year 1; Type: EXPERIMENTAL; Interventions: Behavioral: 4 Pillars Immunization Toolkit | Arm Label: Control Group Year 1; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: 4 Pillars Immunization Toolkit; Assigned to Arm(s): Intervention Group Year 1
C: Arm Label: Participatory; Type: EXPERIMENTAL; Interventions: Behavioral: Participatory | Arm Label: Efficient; Type: EXPERIMENTAL; Interventions: Behavioral: Efficient | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Participatory; Assigned to Arm(s): Participatory | Intervention Type: BEHAVIORAL; Name: Efficient; Assigned to Arm(s): Efficient
D: Arm Label: Dulce family partner intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Project dulce | Arm Label: Safety intervention; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Safety intervention | Intervention Type: BEHAVIORAL; Name: Project dulce; Assigned to Arm(s): Dulce family partner intervention | Intervention Type: BEHAVIORAL; Name: Safety intervention; Assigned to Arm(s): Safety intervention

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Pilot Prospective, Randomized Controlled Trial Assessing the Clinical Impact of Integrated Pharmacogenetic Testing on Selected OASIS Metrics, Re-hospitalizations and Emergency Department Visits
Brief Summary: Patients meeting eligibility criteria will be randomized into two groups, one receiving pharmacogenetic testing and the other not receiving pharmacogenetic testing. In this open-label trial, a pharmacist will make medication therapy recommendations using YouScript® Personalized Prescribing System for patients who receive genetic testing and standard drug information resources per usual for patients who do not undergo pharmacogenetic testing.


Options:
A: Arm Label: Controls ("not tested"); Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Intervention ("tested"); Type: ACTIVE_COMPARATOR; Interventions: Genetic: Pharmacogenetic testing | Intervention Type: GENETIC; Name: Pharmacogenetic testing; Assigned to Arm(s): Intervention ("tested")
B: Arm Label: iCPR randomized providers; Type: EXPERIMENTAL; Interventions: Other: Integrated Clinical Prediction Rule (iCPR) | Arm Label: Control providers; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Integrated Clinical Prediction Rule (iCPR); Assigned to Arm(s): iCPR randomized providers
C: Arm Label: Notification Group; Type: EXPERIMENTAL; Interventions: Behavioral: Notification Group | Arm Label: No Notification; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Notification Group; Assigned to Arm(s): Notification Group
D: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Other: automated clinical alerts, Other: provider education | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Other: provider education | Intervention Type: OTHER; Name: automated clinical alerts; Assigned to Arm(s): 1 | Intervention Type: OTHER; Name: provider education; Assigned to Arm(s): 1, 2

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: AMOS2 (Adolescent Morbid Obesity Surgery)
Brief Summary: Severe childhood obesity is associated with both immediate and chronic health problems and a severe impact on psychosocial development. Medical and behavioural interventions rarely result in the significant, durable weight loss necessary to improve health outcomes.

This is a randomised clinical trial where 50 adolescents, 13-16 years of age, will be randomised to either early bariatric surgery (Roux-en-Y gastric bypass) or intense conservative treatment and possibly surgery after two years of non-surgical treatment or as they have become 18 years.


Options:
A: Arm Label: Bariatric surgery; Type: EXPERIMENTAL; Interventions: Procedure: Laparoscopic Roux-en-Y gastric bypass | Arm Label: Intense conservative treatment; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Intense conservative treatment | Intervention Type: PROCEDURE; Name: Laparoscopic Roux-en-Y gastric bypass; Assigned to Arm(s): Bariatric surgery | Intervention Type: PROCEDURE; Name: Intense conservative treatment; Assigned to Arm(s): Intense conservative treatment
B: Arm Label: Laparoscopic adjustable gastric band; Type: EXPERIMENTAL; Interventions: Procedure: laparoscopic adjustable gastric band, Behavioral: Combined life style interventions | Arm Label: Control group; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Combined life style interventions | Intervention Type: PROCEDURE; Name: laparoscopic adjustable gastric band; Assigned to Arm(s): Laparoscopic adjustable gastric band | Intervention Type: BEHAVIORAL; Name: Combined life style interventions; Assigned to Arm(s): Control group, Laparoscopic adjustable gastric band
C: N/A
D: Arm Label: g-Cath EZ Treatment Group; Type: EXPERIMENTAL; Interventions: Device: g-CathTM EZ Suture Anchor Delivery Catheter | Arm Label: Diet and exercise Control Group; Type: ACTIVE_COMPARATOR; Interventions: Other: Diet and Exercise Control Group | Intervention Type: DEVICE; Name: g-CathTM EZ Suture Anchor Delivery Catheter; Assigned to Arm(s): g-Cath EZ Treatment Group | Intervention Type: OTHER; Name: Diet and Exercise Control Group; Assigned to Arm(s): Diet and exercise Control Group

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: RCT on Care Manager Organization for Management of Mild-moderate Depression in the Primary Care Setting, Sweden
Brief Summary: The aim of the project is to explore if a complementary addition of a care manager for depression treatment in the primary care setting has positive effects concerning reduction of the patients' depressive symptoms as well as improvement of daily function and quality of life in a short- and long-term perspective compared with the traditional Swedish primary care organization. The aim is also to evaluate the care manager function in a health economic perspective.

The specific aims are to develop and evaluate an evidence-based care manager program for patients with mild to moderate depression and to compare the evidence-based care manager program to treatment as usual (TAU) in terms of their short- and long-term effects on symptom remission, treatment adherence, care satisfaction, and self-efficacy as well as to perform a cost - effectiveness analysis of the care manager program, i.e. to evaluate the effects of the program on patients' health in relation to the running costs of the program.


Options:
A: Arm Label: Care manager for depression; Type: EXPERIMENTAL; Interventions: Other: care manager for depression | Arm Label: Treatment As Usual; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: care manager for depression; Assigned to Arm(s): Care manager for depression
B: Arm Label: ACT; Type: EXPERIMENTAL; Interventions: Other: Acceptance and Commitment Therapy (ACT) | Arm Label: WPI; Type: EXPERIMENTAL; Interventions: Other: workplace intervention (WPI) | Arm Label: ACT and WPI; Type: EXPERIMENTAL; Interventions: Other: Acceptance and Commitment Therapy (ACT), Other: workplace intervention (WPI) | Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Acceptance and Commitment Therapy (ACT); Assigned to Arm(s): ACT, ACT and WPI | Intervention Type: OTHER; Name: workplace intervention (WPI); Assigned to Arm(s): ACT and WPI, WPI
C: Arm Label: Tree Theme Method ® (TTM) intervention; Type: EXPERIMENTAL; Interventions: Other: Tree Theme Method ® (TTM) | Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Tree Theme Method ® (TTM); Assigned to Arm(s): Tree Theme Method ® (TTM) intervention
D: Arm Label: Phase B; Type: EXPERIMENTAL; Interventions: Drug: OPC-34712 + ADT, Drug: Placebo + ADT | Arm Label: Phase A; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo + ADT | Intervention Type: DRUG; Name: OPC-34712 + ADT; Assigned to Arm(s): Phase B | Intervention Type: DRUG; Name: Placebo + ADT; Assigned to Arm(s): Phase B | Intervention Type: DRUG; Name: Placebo + ADT; Assigned to Arm(s): Phase A

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effect of Fee on Attendance in Cervical Cancer Screening-results From ScreenFee a Swedish Population Based Randomised Trial
Brief Summary: Several reasons can explain non-attendance in cervical cancer screening. In low resource settings the attendance is even lower. The effect of fee as contributing reason of non attendance has not been studied before why the investigators decided to study this in a low resource setting as a randomised trial.


Options:
A: Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Interactive Preventive Health Record (IPHR) | Arm Label: Control; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: "Standard" preventive care | Intervention Type: BEHAVIORAL; Name: Interactive Preventive Health Record (IPHR); Assigned to Arm(s): Intervention | Intervention Type: BEHAVIORAL; Name: "Standard" preventive care; Assigned to Arm(s): Control
B: Arm Label: Intervention group 1; Type: EXPERIMENTAL; Interventions: Behavioral: HPV self-sampling kit mailed directly | Arm Label: Intervention group 2; Type: EXPERIMENTAL; Interventions: Behavioral: HPV self-sampling kit on demand | Arm Label: Intervention group 3; Type: EXPERIMENTAL; Interventions: Behavioral: Second reminder | Intervention Type: BEHAVIORAL; Name: HPV self-sampling kit mailed directly; Assigned to Arm(s): Intervention group 1 | Intervention Type: BEHAVIORAL; Name: HPV self-sampling kit on demand; Assigned to Arm(s): Intervention group 2 | Intervention Type: BEHAVIORAL; Name: Second reminder; Assigned to Arm(s): Intervention group 3
C: Arm Label: Intervention and control; Type: ACTIVE_COMPARATOR; Interventions: Other: Screening without fee | Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Screening without fee; Assigned to Arm(s): Intervention and control
D: Arm Label: CHWs facilitated Self-Sampling; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: CHW and Self-sampling for Cervical Cancer | Arm Label: Mailed Self-Sampler; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Mailed Self Sampler | Intervention Type: BEHAVIORAL; Name: CHW and Self-sampling for Cervical Cancer; Assigned to Arm(s): CHWs facilitated Self-Sampling | Intervention Type: BEHAVIORAL; Name: Mailed Self Sampler; Assigned to Arm(s): Mailed Self-Sampler

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Saline Hypertonic in Preschoolers
Brief Summary: The purpose of this study is to assess whether inhalation of 7% hypertonic saline (HS) twice daily for 48 weeks improves the lung clearance index by multiple breath nitrogen washout in comparison with inhalation of 0.9% isotonic saline (IS) in preschool children (ages 3 to 5) with cystic fibrosis.


Options:
A: Arm Label: 1; Type: OTHER; Interventions: Drug: rhDNAse, Other: Placebo | Arm Label: 2; Type: OTHER; Interventions: Drug: rhDNAse, Other: Placebo | Intervention Type: DRUG; Name: rhDNAse; Assigned to Arm(s): 1, 2 | Intervention Type: OTHER; Name: Placebo; Assigned to Arm(s): 1, 2
B: Arm Label: Active treatment group; Type: EXPERIMENTAL; Interventions: Drug: 7% Hypertonic Saline (HS) | Arm Label: Control group; Type: ACTIVE_COMPARATOR; Interventions: Drug: 0.9% Isotonic Saline (IS) | Intervention Type: DRUG; Name: 7% Hypertonic Saline (HS); Assigned to Arm(s): Active treatment group | Intervention Type: DRUG; Name: 0.9% Isotonic Saline (IS); Assigned to Arm(s): Control group
C: Arm Label: Active Treatment Group; Type: EXPERIMENTAL; Interventions: Drug: 7% Hypertonic Saline (HS) | Arm Label: Control Group; Type: ACTIVE_COMPARATOR; Interventions: Drug: 0.9% Isotonic Saline (IS) | Intervention Type: DRUG; Name: 7% Hypertonic Saline (HS); Assigned to Arm(s): Active Treatment Group | Intervention Type: DRUG; Name: 0.9% Isotonic Saline (IS); Assigned to Arm(s): Control Group
D: Arm Label: Hypertonic saline; Type: EXPERIMENTAL; Interventions: Drug: Hypertonic Saline | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Hypertonic Saline; Assigned to Arm(s): Hypertonic saline | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo

Answer: C